Article
Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy induced peripheral neuropathy
2022-07-13
Abstract excerpt
<title>Abstract</title> <p>Dose-limiting toxicities significantly impact the benefit/risk profile of many drugs. Whole genome sequencing (WGS) in patients receiving drugs with dose-limiting toxicities can identify therapeutic hypotheses to prevent these toxicities. Peripheral neuropathy (PN) is a common dose-limiting neurological toxicity of chemotherapies with no effective approach for prevention. We conducted a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5ae66efc-6802-5ae9-9392-260ba90c330c
- DOI
- 10.21203/rs.3.rs-1816977/v1
